Tahara Atsuo | Drug Discovery Research Astellas Pharma Inc.
スポンサーリンク
概要
関連著者
-
Tahara Atsuo
Drug Discovery Research Astellas Pharma Inc.
-
Tanaka A
Yamanouchi U.k. Ltd. Surrey Gbr
-
Tanaka A
Faculty Of Pharmaceutical Sciences Tokyo University Of Science
-
増田 明
富山医科薬科大学麻酔科
-
MATSUHISA Akira
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Matsuhisa Akira
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Matsuhisa Akira
Gastrointestinal Research Laboratories Institute For Drug Discovery Research Yamanouchi Pharmaceutic
-
Yatsu Takeyuki
Astellas Pharma Inc. Ibaraki Jpn
-
Matsuhisa Akira
Institute For Drug Discovery Research Astellas Pharma Inc.
-
YATSU Takeyuki
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Yatsu Takeyuki
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
TANIGUCHI Nobuaki
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Taniguchi Nobuaki
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
TANAKA Akihiro
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
SHIMADA Yoshiaki
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Tanaka Akihiro
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Shimada Yoshiaki
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
TANAKA Akihiro
Corporate Communications Department, Yamanouchi Pharmaceutical Co., Ltd.
-
KIKUCHI Kazumi
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Kikuchi Kazumi
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Shibasaki Masayuki
Drug Discovery Research Astellas Pharma Inc.
-
SAKAMOTO Kenichiro
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
Tanaka Akihiro
Corporate Communications Department Yamanouchi Pharmaceutical Co. Ltd.
-
Sakamoto K
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Takasu Toshiyuki
Drug Discovery Research, Astellas Pharma Inc.
-
Tsukada Junko
Clinical Development Department Yamanouchi Pharmaceutical Co. Ltd.
-
Kawano Noriyuki
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
AKANE Hiroaki
Clinical Development Department, Yamanouchi Pharmaceutical Co., Ltd.
-
TAHARA Atsuo
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Akane Hiroaki
Clinical Development Department Yamanouchi Pharmaceutical Co. Ltd.
-
KOSHIO Hiroyuki
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd.
-
Koshio Hiroyuki
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Tomura Yuichi
Drug Discovery Research, Astellas Pharma Inc.
-
Tomura Yuichi
Drug Discovery Research Astellas Pharma Inc.
-
Kurosaki Eiji
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
Yokono Masanori
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
Yamajuku Daisuke
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
Hayashizaki Yuka
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
Imamura Masakazu
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
Qun Li
Applied Pharmacology Research Laboratories, Astellas Pharma Europe B.V., The Netherlands
-
Tomiyama Hiroshi
Product Planning and Coordination Division, Research and Development Department, Kotobuki Pharmaceutical Co., Ltd., Japan
-
Kobayashi Yoshinori
Synthetic Division, Research Laboratories, Kotobuki Pharmaceutical Co., Ltd., Japan
-
Noda Atsushi
Synthetic Division, Research Laboratories, Kotobuki Pharmaceutical Co., Ltd., Japan
-
Sasamata Masao
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
KIHARA Rumi
Drug Discovery Research, Astellas Pharma, Inc.
-
IMAMURA Masakazu
Drug Discovery Research, Astellas Pharma, Inc.
-
TOMIYAMA Hiroshi
Product Planning and Coordination Division, Research and Development Department, Kotobuki Pharmaceutical Co., Ltd.
-
KUROSAKI Eiji
Drug Discovery Research, Astellas Pharma, Inc.
-
SASAMATA Masao
Drug Discovery Research, Astellas Pharma, Inc.
-
KOBAYASHI Yoshinori
Synthetic Division, Research Laboratories, Kotobuki Pharmaceutical Co., Ltd.
-
YAMAJUKU Daisuke
Drug Discovery Research, Astellas Pharma, Inc.
-
YOKONO Masanori
Drug Discovery Research, Astellas Pharma, Inc.
-
Koshio Hiroyuki
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
HAYASHIZAKI Yuka
Drug Discovery Research, Astellas Pharma, Inc.
-
NODA Atsushi
Synthetic Division, Research Laboratories, Kotobuki Pharmaceutical Co., Ltd.
-
QUN Li
Applied Pharmacology Research Laboratories, Astellas Pharma Europe B. V.
-
TOMURA Yuichi
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
KUSAYAMA Toshiyuki
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
WADA Kohichi
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
TSUNODA Takashi
Chemical Technology Laboratory, Yamanouchi Pharmaceutical Co., Ltd.
-
Wada Kohichi
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Kusayama Toshiyuki
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Yanagisawa Isao
Corporate Planning Dept.
-
Tsunoda Takashi
Chemical Technology Laboratory Yamanouchi Pharmaceutical Co. Ltd.
-
Tsukada Junko
Drug Discovery Research Astellas Pharma Inc.
-
Yatsu Takeyuki
Drug Discovery Research Astellas Pharma Inc.
-
Kihara Rumi
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
Takasu Toshiyuki
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
TAKASU Toshiyuki
Drug Discovery Research, Astellas Pharma, Inc.
-
TAHARA Atsuo
Drug Discovery Research, Astellas Pharma, Inc.
-
Tahara Atsuo
Drug Discovery Research, Astellas Pharma, Inc., Japan
-
SHIBASAKI Masayuki
Drug Discovery Research, Astellas Pharma, Inc.
著作論文
- Preparation of Highly Potent and Selective Non-Peptide Antagonists of the Arginine Vasopressin V_ Receptor by Introduction of a 2-Ethyl-1H-1-imidazolyl Group
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 4'-(1,4,5,6-Tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanilide Derivatives and 4'-(5,6-Dihydro-4H-thiazolo[5,4-d][1]ben
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 2-Phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl)benzanilide Derivatives
- Stereoselective Synthesis of Methyl (Z)-(4,4-Difluoro-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylidene) acetate Using a Dianion Horner-Wadsworth-Emmons Reagent
- Preparation of Non-peptide, Highly Potent and Selective Antagonists of Arginine Vasopressin V_ Receptor by Introduction of Alkoxy Groups
- Highly Potent and Orally Active Non-Peptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 4'-[(4,4-Difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-yl)carbonyl]-2-phenylbenzani
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 2-Phenyl-4'-[(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]benzanilide Derivatives
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 4'-[5-(Substituted Methylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl]benzanilide and 4'-[5-(Substituted Methyl)-2,3-dihy
- Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor
- Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin–Nicotinamide-Induced Mildly Diabetic Mice
- Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin-Nicotinamide-Induced Mildly Diabetic Mice